International Journal of Neuropsychopharmacology
banner
ijnp.bsky.social
International Journal of Neuropsychopharmacology
@ijnp.bsky.social
The official journal of
The International College of Neuropsychopharmacology (CINP)
https://linktr.ee/ijnp
They suggest that future research should directly compare oral and depot naltrexone, systematically assess blinding, and account for comorbidities and sex differences to clarify ketamine’s mechanisms of action and guide clinical practice

Check the paper for + info: doi.org/10.1093/ijnp...
November 14, 2025 at 7:45 PM
A recent commentary by @igorbandeira.bsky.social et al. highlights the steps in clinical trial design that combine ketamine and naltrexone for major depression, allowing for a mechanistic approach.

@stanfordpsy.bsky.social
#depression #opiod #ketamine #resistantdepression #clinicaltrials
November 14, 2025 at 7:45 PM
💊 Distinct D₂R binding poses may produce clinically meaningful differences in efficacy, onset, and tolerability

📄 Read the full study here: doi.org/10.1093/ijnp...
Partial agonist antipsychotic drugs differentially interact with a secondary binding site at the dopamine D2 receptor
Highlights - Aripiprazole and brexpiprazole showed significantly increased dissociation from the dopamine D2 receptor upon L94A mutation, indicating that t
doi.org
November 7, 2025 at 12:57 PM
⚙️ Mechanistic insight:
Aripiprazole / brexpiprazole → SBP-dependent binding
→ May help stabilize dopaminergic tone and reduce extrapyramidal side effects.

Cariprazine / lumateperone → canonical D₂R binding, faster dynamics
→ Could underlie different temporal or regional dopamine modulation.
Partial agonist antipsychotic drugs differentially interact with a secondary binding site at the dopamine D2 receptor
Highlights - Aripiprazole and brexpiprazole showed significantly increased dissociation from the dopamine D2 receptor upon L94A mutation, indicating that t
doi.org
November 7, 2025 at 12:57 PM
🧩 In this study, 4 clinically approved D₂R partial agonists (DPAs) were tested for how they interact w/ a secondary binding pocket (SBP) in the receptor

🔬 Key finding:
Mutating a residue in the SBP(L94A) accelerated dissociation of aripiprazole and brexpiprazole, but not cariprazine or lumateperone
November 7, 2025 at 12:57 PM
Given prolactin’s roles in mood, stress, sexual health, and bone metabolism, early endocrine assessment could inform sex-specific care in schizophrenia.

🔗 Read +: doi.org/10.1093/ijnp...
#Schizophrenia #Endocrinology #Psychiatry #FirstEpisodePsychosis #Neuroendocrinology
Sex-specific prolactin disturbance and divergent gonadal hormone correlates in first-episode schizophrenia
AbstractBackground. Hyperprolactinemia and altered prolactin (PRL) levels are well-documented in schizophrenia. However, very few studies have investigated
doi.org
October 27, 2025 at 1:16 PM
📊 Abnormal PRL levels were nearly 4× more frequent in males than in females.
📊 HyperPRL patients also showed higher testosterone and FSH

These findings suggest that PRL–gonadal hormone dysregulation may be intrinsic to psychosis onset, not only drug-induced.
October 27, 2025 at 1:16 PM
🔥In aged mice, gut dysbiosis worsened POCD by increasing brain inflammation.

💊Treatment with the probiotic VSL#3 restored healthy gut bacteria, reduced neuroinflammation, and improved memory via the AMPK/SIRT1 pathway, a key regulator of energy balance and inflammation ⚡
October 24, 2025 at 1:58 PM
🧠 Confirmed NET Occupancy:~30-40% at therapeutic doses with no differences in avaiability pre and post treatment
📈 Clinical Correlation: NET availability associated with clinical improvement
⚖️ Synergy: NET + SERT occupancy (~80%) reinforce efficacy in MDD
October 17, 2025 at 12:02 PM
By integrating personality dimensions into diagnostic evaluation, the study opens new perspectives for refining classification and advancing personalized treatment strategies in psychiatry.

Check the paper to find more: doi.org/10.1093/ijnp...
Validate User
doi.org
October 10, 2025 at 11:40 AM
This reinforces that lithium modulates unique metabolic mechanisms. However, predicting who will respond remains a complex challenge that has not yet been solved by blood metabolomics.

Read more here: doi.org/10.1093/ijnp...

#BipolarDisorder #Psychiatry #Lithium #MoodStabilizers
Identification of peripheral biomarkers through metabolomic analysis in patients with bipolar disorder treated with mood stabilizers: an exploratory study
AbstractImportance. Bipolar disorder (BD) is mainly treated with mood stabilizers, among which lithium represents the gold standard. Despite its high clini
doi.org
October 3, 2025 at 11:31 AM
A new study investigated this by analyzing the blood metabolome of BD patients
✅ Lithium & other MS have different metabolic signatures in pathways involving glucose, pyruvate and glutamate metabolism
❌ The study found no significant differences between responders and non-responders
#Metabolomics
October 3, 2025 at 11:31 AM
These findings argue for the assessment of anhedonia in clinical practice to better guide treatment management

Read+: doi.org/10.1093/ijnp...
Anhedonia is associated with a specific depression profile and poor antidepressant response
AbstractBackground. Anhedonic features within major depressive disorder (MDD) have been associated with worse course and outcome and may predict nonrespons
doi.org
September 26, 2025 at 1:50 PM
💊Findings reveal a treatment-resistance profile for the anhedonic #MDD. Data suggests #SSRIs may be less effective to non-anhedonic MDD, supporting the need for targeted, non-5HT therapeutic strategies
Anhedonia is associated with a specific depression profile and poor antidepressant response
AbstractBackground. Anhedonic features within major depressive disorder (MDD) have been associated with worse course and outcome and may predict nonrespons
doi.org
September 26, 2025 at 1:50 PM
🦋 The MDD profile was related to specific somatic comorbidities, notably thyroid dysfunction and Type 2 Diabetes Mellitus #T2DM. The link highlights the possible role of disruption in reward circuitry and endocrine function.
September 26, 2025 at 1:50 PM